PLA2G2A and myeloid sarcoma: Although the EAE model has been questioned recently in terms of its validity for identifying potential MS therapies [25,26], the model is clearly useful to help define the role of inflammatory enzymes, specifically the PLA2s, in autoimmune attack of the nervous system.